Acute renal failure in kidney transplant patients treated with interferon alpha 2b for chronic hepatitis c

Nephron

Volumn 74, Issue 3, 1996, Pages 512-516

  Rosiaing, Lionel ^a   Modesto, Anne ^b   Baron, Emmanuel ^a   Cisterne, Jean Marc ^a   Chabannier, Marie Hélène ^a   Durand, Dominique ^a  

^a Service de Néphrologie   (France)

^b CHU RANGUEIL   (France)

Author keywords

Acute renal failure; Alpha interferon; Chronic hepatitis C; Renal transplantation

Indexed keywords

ANTIVIRUS AGENT; CREATININE; CYCLOSPORIN A; RECOMBINANT ALPHA2B INTERFERON;

ACUTE KIDNEY FAILURE; ADULT; ARTICLE; CAPILLARY; CHRONIC HEPATITIS; CLINICAL ARTICLE; CREATININE BLOOD LEVEL; FEMALE; GLOMERULUS; HEPATITIS C; HISTOLOGY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATORY INFILTRATE; KIDNEY BIOPSY; KIDNEY FUNCTION; KIDNEY INTERSTITIUM; KIDNEY TRANSPLANTATION; MALE; PRIORITY JOURNAL; PROTEINURIA; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0029905719     PISSN: 16608151     EISSN: 22353186     Source Type: Journal    
DOI: 10.1159/000189444     Document Type: Article

References (23)

1. Rolli D, Zucker K, Cirocco C, Demaltos A, Burke GW, Esquenazi V, Bobisclikin S, Miller J: The impact of hepatitis C virus infection on renal allograft recipients, Kidney Int 1994,45: 238-244.
2. Davis GL, Baiart LA, Schiff ER, Lindsay K, Bodcnheimcr HC, Perillo RP, Carey W, Jacobson IM, Payne J, Dienstag JL, Van Thiel DH, Tamburro C, Lefkowitch J, Albrecht J, Mes-chicvitz C, Onego TJ, Gibas A, and the hepatitis international therapy group: Treatment of chronic hepatitis C with recombinant interferon alpha, N Engl J Med 1989:321:1501-1505.
3. Saracco G, Rosina F, Abate ML, Chiandussi L, Gallo V, Ccrutti E, DiNapoli A, Solinas A, Deplano A, Tocco A, Cossu P, Chien D, Kuo G, Polito A, Weiner AJ, Houghton M, Vcrmc G, Bonino F, Rizzetto M: Long-term follow-up of patients with chronic hepatitis C treated with different doses of interferon-a 2b, Hepatology 1993:18:1300-1305.
4. Quesada JR, Talpaz M, Rios A, Kurzrock R, Gutterman JV: Clinical toxicity of interferons in cancer patients: A review, J Clin Oncol 1986: 4:234-243.
5. Selby P, Kohn J, Raymond J, Judson I, McEl-wain T: Nephrotic syndrome during treatment with interferon, BrMcd J 1985:290:1180.
6. Traynor A, Kuzel T, Samuelson E, Kanwar Y: Minimal-change glomerulopathy and glomerular visceral epithelial hyperplasia associated with alpha-interferon therapy for cutaneous T-cell lymphoma, Nephron 1994:67:94-100.
7. Kimmel PL, Abraham AA, Phillips TM: Mem-brano-proliferative glomerulonephritis in a patient treated with interferon-a for human immunodeficiency virus infection, Am J Kidney Dis 1994;24:858-863.
8. Herrman J, Gabriel F: Membrano-prolifcrative glomerulonephritis in a patient with hairy-cell leukemia treated with alpha-11 interferon, N Engl J Med 1987:316:112-113.
9. Nair S, Johnston JO, Ernstoff MS, Downs MA, Bahnson RR, Neuhart J, Arthur S, Kirkwood JM: Interferon-induced reversible acute renal failure with nephrotic syndrome, Urology 1992:34:169-172.
10. Fahal IH, Murry N, Chu P, Bell JM: Acute renal failure during interferon treatment, BMJ 1993:306:973.
11. Noel C, Vrtovsnik F, Façon T, Noel-Walter MP, Hazzan M, Jouet JP, Baulers F, Lelièvre G: Acute and definitive renal failure in progressive multiple myeloma treated with recombinant interferon a!pha-2a: Report on two patients, Am J Hematol 1993:41:298-299.
12. Jadoul M, Picssevaux H, Ferrant A, Cosyns JP, van Yperscle de Strihou C: Renal thrombotic microangiopathy in patients with chronic myelogenous leukaemia treated with interferon 2b, Nephrol Dial Transplant 1995:10:111-113.
13. Averbuch SD, Austin HA, Sherwin SA, Anton-ovytch T, Bunn PA, Longo DL: Acute interstitial nephritis with the nephrotic syndrome following recombinant leucocyte A interferon therapy for mycosis fungoidcs, N Engl J Med 1984:310:32-35.
14. Durand JM, Rclomaz F, Crelel E, Kaplanski G, Soubcvrand J: Glomérulonéphrite extracapillaire au cours d'un traitement par interféron alpha, Rev Méd Interne 1993:14:1138.
15. Kramer P, Ten Kate FWJ, Bijncn AB, Jeekcl J, Weimar W: Recombinant leucocyte interferon A induces steroid-resistant acute vascular rejection episodes in renal transplant recipients, Lancet 1984:Vol i:989-990.
16. Kovarik J, Mayer G, Pohanka E, Schwarz M, Traindl O, Graf H, Smolcn J: Adverse effect of low-dose prophylactic human recombinant leucocyte interferon-alpha treatment in renal transplant recipients, Transplantation 1988: 45:402-405.
17. Magnone M, Holley JL, Shapiro R, Scantlebu-ry V, McCauley J, Jordan M, Vivas C, Starzl T, Johnson JP: Inteferon-a-induced acute allograft rejection, Transplantation 1995:59:1068-1070.
18. Solez K, Axelsen RA, Benediktsson H, Birdick JF, Cohen AH, Croker BP, Droz D, Dundill MS, Halloran PF, Häyry P, Jenette JC, Keown PA, Marcussen N, Mihatch MJ, Morozumi K, Myers BD, Nast CC, Olson S, Racussen LC, Ramos EL, Rosen S, Sachs DH, Salomon DR, Sanfilippo F, Verani R, Von Willebrandt E, Yamaguchi Y: International standardization of criteria for the histologic diagnosis of renal allograft rejection: The Banff working classification of kidney transplant pathology, Kidney Int 1993:44:411-422.
19. Lui SF, Ali AA, Grundy JE, Fernando ON, Griffiths PD, Sweny P: Double-blind, placebo-controlled trial of human lymphoblastoid interferon prophylaxis of cytomegalovirus infections in renal transplant recipients, Nephrol Dial Transplant 1992;7:1230-1237.
20. Hirsch MS, Schooley RT., Cosimi AB, Russel PS, Delmonico FL., Tolkoff-Rubin NE, Herrin JT, Cantcll K, Farrell ML, Rota TR, Rubin RH: Effects of interferon alpha on cytomegalovirus reactivation syndromes in renal transplant recipients, N Engl J Med 1983:308:1489-1493.
21. Mord-Maroger L, Shipper JC, Vinter J, Woodrow D, Grosser I: An ultrastructural study of the development of nephritis in mice treated with interferon in the neonatal period, Lab Invest 1978:39:513-522.
22. Slater AD, Klein JB, Sonnenfeld G, Ogden LL, Gray LA: The effects of interferon alpha/beta in a model of rat heart transplantation, J Heart LungTransplant 1992;11:975-978.
23. Ault BH, Brudcr-Staplcton F, Gaber L, Martin A, Roy S, Murphy SB: Acute renal failure during therapy with recombinant human gamma interferon, N Eng] J Med 1988:319:1397-1400.